Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...

Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...

The following is a summary of “Associations of serum sclerostin levels with body composition, pulmonary function, and ...

A total of 161 COPD patients completed at least one CAT questionnaire at baseline, 75 at exacerbation and 52 of these patients completed the CAT questionnaire daily during exacerbation recovery.

点击上方“Vaccine前研”，关注最新疫苗动态慢性阻塞性肺疾病是全球一大呼吸疾病难题，若处理不善，其致命性不容小觑，且常被低估。此病乃全球死亡率与发病率之重要推手。吸烟，作为慢性阻塞性肺疾病之主要诱因，据世界卫生组织(WHO)数据，约旦18岁以上男 ...

Chronic obstructive pulmonary disease (COPD) management relies on pulmonary function tests to evaluate lung function and tailor patient-specific therapies. Why are pulmonary function tests crucial in ...

Background: Limited data are available comparing air travel with the hypoxia inhalation test (HIT) in passengers with COPD. The aim of this study was to assess the predictive capability of the HIT ...

A five-year-old cat that was surrendered to a shelter for an "absurd" reason has found a new forever home. Byakuva was brought to Orange County Animal Services (OCAS) because he "ate too much ...

Some people, however, are at higher risk, including children and people with asthma, COPD, heart disease, diabetes, chronic kidney disease, or who are pregnant. "It's important for everyone to ...

Age Friendly Roscrea have started a COPD support group for those with chronic conditions related to breathing. The group meets on Tuesdays at 2.30pm in Roscrea Leisure Centre for an exercise class and ...

Glycopyrrolate (brand name, Seebri Neohaler) is an anticholinergic medicine used as a long-term maintenance treatment of airflow obstruction in people with COPD. It has been approved in more than 80 ...

Ipratropium (brand name, Atrovent HFA; Boehringer-Ingelheim) is a short-acting bronchodilator. It is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with COPD.